Cargando…
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience
Stringent measures have been taken to contain COVID-19 spread, limiting access only for urgent visits, surgery procedures, or hospitalizations and using teledermatology services for non-urgent cases. Management of oncological patients affected by chemo-, immune-, and radiotherapy-related cutaneous a...
Autores principales: | Cinelli, Eleonora, Fabbrocini, Gabriella, Fattore, Davide, Marasca, Claudio, Damiani, Giovanni, Annunziata, Maria Carmela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276658/ https://www.ncbi.nlm.nih.gov/pubmed/32514616 http://dx.doi.org/10.1007/s00520-020-05563-1 |
Ejemplares similares
-
Chronic cutaneous ulcers management in dermatologic department during COVID‐19 era
por: Zagaria, Orlando, et al.
Publicado: (2020) -
Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer
por: Annunziata, Maria Carmela, et al.
Publicado: (2019) -
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study
por: Ruggiero, Angelo, et al.
Publicado: (2021) -
A safe distance between doctor and patient
por: Hwang, Kun
Publicado: (2020) -
Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management
por: Fattore, Davide, et al.
Publicado: (2022)